Wagner Wealth Management LLC Takes $126,000 Position in MetLife (MET)

Wagner Wealth Management LLC acquired a new position in shares of MetLife (NYSE:MET) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,350 shares of the financial services provider’s stock, valued at approximately $126,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in MET. New York State Common Retirement Fund grew its stake in MetLife by 3.3% during the third quarter. New York State Common Retirement Fund now owns 2,467,700 shares of the financial services provider’s stock worth $128,197,000 after buying an additional 78,600 shares during the period. Fuller & Thaler Asset Management Inc. grew its stake in MetLife by 14.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 12,200 shares of the financial services provider’s stock worth $634,000 after buying an additional 1,500 shares during the period. Tdam USA Inc. grew its stake in MetLife by 4.6% during the third quarter. Tdam USA Inc. now owns 168,070 shares of the financial services provider’s stock worth $8,731,000 after buying an additional 7,389 shares during the period. ETRADE Capital Management LLC grew its stake in MetLife by 111.8% during the third quarter. ETRADE Capital Management LLC now owns 31,843 shares of the financial services provider’s stock worth $1,654,000 after buying an additional 16,805 shares during the period. Finally, AGF Investments Inc. grew its stake in MetLife by 6.6% during the third quarter. AGF Investments Inc. now owns 1,293,464 shares of the financial services provider’s stock worth $67,195,000 after buying an additional 79,529 shares during the period. Institutional investors own 77.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several equities research analysts have issued reports on MET shares. Wells Fargo set a $62.00 price objective on shares of MetLife and gave the stock a “buy” rating in a research note on Thursday, December 14th. Zacks Investment Research downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research note on Monday, December 18th. Deutsche Bank started coverage on shares of MetLife in a research note on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price objective for the company. Goldman Sachs reiterated a “buy” rating on shares of MetLife in a research note on Wednesday, January 31st. Finally, ValuEngine downgraded shares of MetLife from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. MetLife has an average rating of “Hold” and a consensus price target of $57.90.

Shares of MetLife stock opened at $44.08 on Friday. The stock has a market cap of $45,695.22, a price-to-earnings ratio of 8.89, a P/E/G ratio of 0.89 and a beta of 1.28. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.29. MetLife has a twelve month low of $43.38 and a twelve month high of $55.91.

MetLife (NYSE:MET) last posted its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by ($0.41). The company had revenue of $15.79 billion during the quarter, compared to analyst estimates of $15.89 billion. MetLife had a net margin of 5.69% and a return on equity of 8.59%. During the same period in the prior year, the company earned $1.28 earnings per share. equities analysts predict that MetLife will post 4.93 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 13th. Investors of record on Monday, February 5th were issued a $0.40 dividend. The ex-dividend date was Friday, February 2nd. This represents a $1.60 annualized dividend and a yield of 3.63%. MetLife’s dividend payout ratio is presently 46.92%.

COPYRIGHT VIOLATION NOTICE: “Wagner Wealth Management LLC Takes $126,000 Position in MetLife (MET)” was first published by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3299984/wagner-wealth-management-llc-takes-126000-position-in-metlife-met.html.

MetLife Profile

MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Brokerages Expect Spark Therapeutics  Will Announce Quarterly Sales of $53.82 Million
Zacks: Brokerages Expect Spark Therapeutics Will Announce Quarterly Sales of $53.82 Million
USDe  Price Hits $0.0002 on Exchanges
USDe Price Hits $0.0002 on Exchanges
DigiPulse  Reaches 24 Hour Trading Volume of $211,967.00
DigiPulse Reaches 24 Hour Trading Volume of $211,967.00
1337 Price Reaches $0.0005
1337 Price Reaches $0.0005
Nicolet Bankshares  Receives $61.25 Average Target Price from Analysts
Nicolet Bankshares Receives $61.25 Average Target Price from Analysts
Marinus Pharmaceuticals, Inc.  Receives $18.75 Average Target Price from Analysts
Marinus Pharmaceuticals, Inc. Receives $18.75 Average Target Price from Analysts


© 2006-2018 Ticker Report. Google+.